HYBRIDIZE THERAPEUTICS

hybridize-therapeutics-logo

Hybridizeโ€™s overarching goal is to help patients overcome untreatable viral diseases.

#People #Website #More

HYBRIDIZE THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care

Founded:
2019-01-01

Address:
Leiden, Zuid-Holland, The Netherlands

Country:
The Netherlands

Website Url:
http://www.hybridizetherapeutics.com

Total Employee:
1+

Status:
Active

Contact:
+31-617524713

Email Addresses:
[email protected]

Technology used in webpage:
Google Maps Google Maps API Google Maps For Work



Current Advisors List

michael-r-hodges_image

Michael R Hodges Strategic Advisory Board @ Hybridize Therapeutics
Advisor
2021-07-01

Current Employees Featured

eline-van-beest_image

Eline van Beest
Eline van Beest Chief Executive Officer @ Hybridize Therapeutics
Chief Executive Officer
2020-06-01

not_available_image

Bianca Matthee
Bianca Matthee Chief Operating Officer @ Hybridize Therapeutics
Chief Operating Officer
2021-01-01

Official Site Inspections

http://www.hybridizetherapeutics.com

  • Host name: 66.8.205.92.host.secureserver.net
  • IP address: 92.205.8.66
  • Location: Germany
  • Latitude: 51.4476
  • Longitude: 7.0122
  • Timezone: Europe/Berlin

Loading ...

More informations about "Hybridize Therapeutics"

Hybridize Therapeutics

Background Hybridize Therapeutics & the rich ecosystem in Leiden. Our background. Hybridize is a spin-off from the Leiden University Medical Center (LUMC). The LUMC has been a frontrunner in both Nephrology & RNA-based โ€ฆSee details»

Hybridize Therapeutics - Crunchbase Company Profile โ€ฆ

Kidney Targeted RNA Therapeutics: RNA-based therapies designed to protect kidneys by targeting specific kidney cells, aiming to treat acute and chronic โ€ฆSee details»

Hybridize Therapeutics - PitchBook

Hybridize Therapeutics General Information Description. Developer of an RNA-based therapy technology intended for patients with acute and chronic kidney โ€ฆSee details»

Hybridize Therapeutics - Leiden, Netherlands - bionity.com

Feb 14, 2022 hybridizetherapeutics.com. Contact. Profile News. Contact. About Hybridize Therapeutics. Hybridize Therapeutics is a spin-off from the Department of Nephrology at the Leiden University Medical Center (LUMC). The LUMC has played pioneering role in both nephrology (kidney dialysis) and RNA-based medicine (oligonucleotide chemistry and โ€ฆSee details»

Hybridize Therapeutics | LinkedIn

Hybridize Therapeutics | 1,179 followers on LinkedIn. Helping patients overcome untreated kidney diseases with RNA-based therapies | Hybridize's mission is to help patients overcome untreated kidney diseases. We do this by developing RNA-based therapies. Currently, we are nearing Phase 1 clinical trials (together with our partner AiCuris Anti-Infectives) for our therapy against โ€ฆSee details»

Press room - Hybridize Therapeutics

Hybridize Therapeutics is a spin-off from the Leiden University Medical Center (LUMC). The LUMC has been a frontrunner in both Nephrology & RNA-based medicine since 1943.See details»

Overview, News & Similar companies - ZoomInfo.com

View Hybridize Therapeutics (www.hybridizetherapeutics.com) location in South Holland, Netherlands , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»

Drug pipelines, Patents, Clinical trials - Synapse - Patsnap

Explore Hybridize Therapeutics with its drug pipeline, therapeutic area, technology platform, 2 news, Disease Domain:Infectious Diseases, Technology Platform:ASO, Unknown, asPNA, Drug:HYB_JCV(Hybridize Therapeutics), HYB BKV, JC virus infection therapeutics (Hybridize Therapeutics), HYB_fib(Hybridize Therapeutics).See details»

Hybridize Therapeutics - VentureRadar

"Hybridize Therapeutics (2019) is a biotech spin-off out of the Leiden University Medical Center with a rich history in research & development in RNA-based therapies.See details»

Hybridize Therapeutics - Products, Competitors, Financials, โ€ฆ

Hybridize Therapeutics focuses on developing RNA-based therapies for kidney diseases within the biopharmaceutical industry. Use the CB Insights Platform to explore Hybridize Therapeutics's full profile.See details»

Hybridize Therapeutics Overview | SignalHire Company Profile

Summary. Hybridize's mission is to help patients overcome untreated kidney diseases. We do this by developing RNA-based therapies. Currently, we are nearing Phase 1 clinical trials (together with...See details»

AiCuris and Hybridize Therapeutics enter worldwide โ€ฆ

Feb 9, 2022 AiCuris acquires exclusive rights to develop and commercialize Hybridizeโ€™s program to prevent severe disease from BK virus (BKV) infections in immunocompromised patients Both companies to collaborate in further โ€ฆSee details»

Hybridize - lifesciencesatwork.nl

N a yearly basis, more than 80,000 patients worldwide suffering from end-stage renal disease obtain a lease-on-life by receiving a donated kidney, dramatically improving their quality of life. While immunosuppression is essential to avoid rejection of the donor kidney, it also dramatically increases the risk of infection. Especially problematic in this setting is BK virus (BKV), a โ€ฆSee details»

Hybridize Therapeutics - Mibiton

Hybridize Therapeutics is developing RNA therapeutics to treat kidney diseases. Current focus areas are the BK virus- and fibrosis programs. The BK-virus program aims to develop an antisense oligonucleotide therapy to supress virus expression after a kidney transplantation.See details»

Hybridize: Developing RNA Platform for Antiviral Therapies

Case Hybridize Therapeutics: developing new platform technology for anti-viral therapies. We met with Dr. Eric van der Veer, CSO and co-founder of Hybridize Therapeutics B.V., to discuss their being awarded a โ‚ฌ250,000 loan from the NWO Take-off 2 program, gain insight into the plans of the company, and hear about their experiences of receiving funding application support from โ€ฆSee details»

Hybrid Biotherapeutics - Crunchbase Company Profile & Funding

Organization. Hybrid Biotherapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Hybrid Bio is a startup biotech business founded by a group of individuals looking to develop a unique cell therapy strategy for cancer. Irvine, California, United States; 1-10;See details»

The Bloom Organization, LLC | Healthcare Mergers & Acquisitions ...

The Bloom Organization brings to the table a deep knowledge about the physician-centric businesses, which is why I enjoy working alongside them in transactions. Legal and business issues are intertwined in the healthcare field, so I need to work alongside a firm like Bloom to be deliver the best possible work product to the client. ...See details»

Cookie Policy (EU) - hybridizetherapeutics.com

This Cookie Policy was last updated on August 12, 2023 and applies to citizens and legal permanent residents of the European Economic Area and Switzerland.See details»

Hybrid Organizations | Meaning, Examples and Advantages

What is a Hybrid Organization? โ€ Hybrid organization is one that mixes elements, value systems and action logics (e.g. social impact and profit generation) of various sectors of society, i.e. the public sector, the private sector and the voluntary sector. A more general notion of hybridity can be found in Hybrid institutions and governance.See details»

Talent & Organization Consulting

Synapsez Talent & Organization Consulting is an international Talent & Organization Consulting company focusing on high-end Organization Development and provision of Strategic HR solutions across all industries. Developing Human Capital, Diagnosing and Recommending effective solutions for structures,systems and processes within Organizations (Companies, Divisions, โ€ฆSee details»